Product image of Yescarta (Axicabtagene Ciloleucel) supplied by GNH India

Yescarta

Active Ingredient:
Axicabtagene Ciloleucel
Origin:
EU

Yescarta (Axicabtagene Ciloleucel)

Yescarta (axicabtagene ciloleucel) is a prescription CAR T-cell therapy for certain blood cancers. It is an individualized treatment made from a patient’s own immune cells. Yescarta is given as a single infusion in a certified medical center.

Manufacturer / TM Owner

Kite Pharma Eu B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

Indications & Clinical Uses

  • Yescarta is used to treat adults with large B-cell lymphoma that has not responded to or has returned after at least two other types of treatment. It is also indicated for adults with follicular lymphoma that has not responded to or has returned after at least two other treatments. Yescarta is a form of immunotherapy designed to help the immune system recognize and attack cancer cells.

Side Effects

  • After infusion, patients may experience flu-like symptoms such as fever, chills, or fatigue as the body responds to treatment. Some people notice changes in blood pressure or heart rate during the infusion period. These effects are typically monitored closely by healthcare professionals.

Precautions & Warnings

  • Yescarta is given in a hospital or clinic equipped to manage severe reactions. Patients should stay near the treatment center for several weeks after infusion. It is important to report any new or worsening symptoms, such as confusion or difficulty breathing, immediately to a healthcare provider.

Avoid Interactions

  • There are no known drug interactions with axicabtagene ciloleucel itself, but other medications taken before or after treatment may affect how the body responds. Patients should inform their doctor about all prescription, over-the-counter, and herbal products they are using. Live vaccines are generally avoided during treatment.

Frequently Asked Questions

Yescarta is used to treat certain types of large B-cell lymphoma and follicular lymphoma in adults who have not responded to other treatments.

Yescarta is given as a single intravenous infusion in a specialized medical center after a patient’s immune cells are collected and modified.

Common effects include fever, chills, fatigue, and changes in blood pressure during or after infusion.

No, Yescarta must be administered at a certified treatment center with experience in CAR T-cell therapy.

Recovery varies by patient; some may need several weeks of monitoring for side effects and immune response.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated:

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Axicabtagene Ciloleucel

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT